Aminov Erez's Form 4 filing
Mira Pharmaceuticals, Inc. (MIRA) · filed May 22, 2024
- Accession no.
- 0001493152-24-021069
- Filed
- May 22, 2024
- Trade date
- May 21, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market purchases total $8.18K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aminov ErezCIK 0001986112 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Common Stock | PPurchaseAcquired | +2,000 | $1.00 | +$2,000 | 375,500 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $1.03 | +$1,030 | 376,500 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +500 | $1.02 | +$510 | 377,000 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +2,000 | $0.84 | +$1,680 | 379,000 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $0.85 | +$850 | 380,000 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +600 | $0.87 | +$522 | 380,600 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +800 | $1.01 | +$808 | 381,400 | Direct | |
| May 21, 2024 | Common Stock | PPurchaseAcquired | +800 | $0.97 | +$776 | 382,200 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.